Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06751056 · ClinicalTrials.gov registry record · NA
Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch
A NA study of Pruritus, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06751056 is a NA study of Pruritus that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 12 participants, below the 110-participant average among 12 other Pruritus trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06751056, a NA study of Pruritus, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if cervical traction is an effective treatment to reduce GABAergic medication use for scalp, arm, and upper back neuropathic itch.
Conditions Studied
Interventions
- DEVICE Cervical Traction Device
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2027-01-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06751056
The ClinicalTrials.gov registry entry for NCT06751056 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 110-participant average among 12 other Pruritus trials with a reported enrollment target (89% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pruritus appearing as the primary indexed condition, and to 1 intervention - of which Cervical Traction Device is the first listed.
NCT06751056 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT06751056 about?
NCT06751056 is a clinical study titled "Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch". The purpose of this study is to determine if cervical traction is an effective treatment to reduce GABAergic medication use for scalp, arm, and upper back neuropathic itch.
What is the current status of trial NCT06751056?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-06-01. Estimated completion is 2027-01-10.
What conditions does trial NCT06751056 study?
This clinical trial studies the following conditions: Pruritus.
What interventions are being tested in trial NCT06751056?
The interventions under investigation include: Cervical Traction Device (DEVICE).
Who is sponsoring clinical trial NCT06751056?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06751056 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pruritus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis
RECRUITING · NA
-
VR-PMR for Post-Burn Symptoms
RECRUITING · NA
-
Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients
COMPLETED · NA
-
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
RECRUITING · Phase 3
-
Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic Stimuli
COMPLETED · Early Phase 1
-
Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.